Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Timothy Back"'
Autor:
Curtis C. Harris, Robert H. Wiltrout, Victor E. Laubach, Eilene Gruys, Timothy Back, Jonathan Weiss, Diana Haines, Draginja Djurickovic, Ewy Mathe, Giang Nguyen, Jonathan Schwank, Mark Bernard, Anne B. Hofseth, Leah Mechanic, Glenwood E. Trivers, Lorne J. Hofseth, Jeffery Subleski, Peijun He, S. Perwez Hussain
Nitric oxide (NO•), an important signaling molecule and a component of inflammatory response, is involved in tumorigenesis. However, the quantity of NO• and the cellular microenvironment influences the role of NO• in tumor development. We used
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a9549de40087fac6fdd5f81ff34f8bba
https://doi.org/10.1158/0008-5472.c.6497316
https://doi.org/10.1158/0008-5472.c.6497316
Autor:
Curtis C. Harris, Robert H. Wiltrout, Victor E. Laubach, Eilene Gruys, Timothy Back, Jonathan Weiss, Diana Haines, Draginja Djurickovic, Ewy Mathe, Giang Nguyen, Jonathan Schwank, Mark Bernard, Anne B. Hofseth, Leah Mechanic, Glenwood E. Trivers, Lorne J. Hofseth, Jeffery Subleski, Peijun He, S. Perwez Hussain
Supplementary Figure 7 from Nitric Oxide Is a Key Component in Inflammation-Accelerated Tumorigenesis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e129a925f517c39069fceb96e5f5b7fd
https://doi.org/10.1158/0008-5472.22374057.v1
https://doi.org/10.1158/0008-5472.22374057.v1
Autor:
Robert H. Wiltrout, Sylvie Guichard, John R. Ortaldo, Tim Chan, Timothy Back, Jonathan M. Weiss, Qun Jiang
Supplementary Figure 1 from mTOR Kinase Inhibitor AZD8055 Enhances the Immunotherapeutic Activity of an Agonist CD40 Antibody in Cancer Treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2424f9589b048d07db779024630e5019
https://doi.org/10.1158/0008-5472.22387920.v1
https://doi.org/10.1158/0008-5472.22387920.v1
Autor:
Robert H. Wiltrout, Sylvie Guichard, John R. Ortaldo, Tim Chan, Timothy Back, Jonathan M. Weiss, Qun Jiang
Supplementary Figure 4 from mTOR Kinase Inhibitor AZD8055 Enhances the Immunotherapeutic Activity of an Agonist CD40 Antibody in Cancer Treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5e284d259c7ab3673820c738fdf356d
https://doi.org/10.1158/0008-5472.22387911.v1
https://doi.org/10.1158/0008-5472.22387911.v1
Autor:
Robert H. Wiltrout, Sylvie Guichard, John R. Ortaldo, Tim Chan, Timothy Back, Jonathan M. Weiss, Qun Jiang
Supplementary Figure 3 from mTOR Kinase Inhibitor AZD8055 Enhances the Immunotherapeutic Activity of an Agonist CD40 Antibody in Cancer Treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa20b16aa0ed0b4c11a9c63dec5eeeba
https://doi.org/10.1158/0008-5472.22387914
https://doi.org/10.1158/0008-5472.22387914
Autor:
Curtis C. Harris, Robert H. Wiltrout, Victor E. Laubach, Eilene Gruys, Timothy Back, Jonathan Weiss, Diana Haines, Draginja Djurickovic, Ewy Mathe, Giang Nguyen, Jonathan Schwank, Mark Bernard, Anne B. Hofseth, Leah Mechanic, Glenwood E. Trivers, Lorne J. Hofseth, Jeffery Subleski, Peijun He, S. Perwez Hussain
Supplementary Figure 9 from Nitric Oxide Is a Key Component in Inflammation-Accelerated Tumorigenesis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01a0db9d58d9d3fd36b6d25d549c1046
https://doi.org/10.1158/0008-5472.22374051
https://doi.org/10.1158/0008-5472.22374051
Autor:
Robert H. Wiltrout, Sylvie Guichard, John R. Ortaldo, Tim Chan, Timothy Back, Jonathan M. Weiss, Qun Jiang
Supplementary Figure 5 from mTOR Kinase Inhibitor AZD8055 Enhances the Immunotherapeutic Activity of an Agonist CD40 Antibody in Cancer Treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23fcc75804fada2875fa322fa1df9ff1
https://doi.org/10.1158/0008-5472.22387908
https://doi.org/10.1158/0008-5472.22387908
Autor:
Curtis C. Harris, Robert H. Wiltrout, Victor E. Laubach, Eilene Gruys, Timothy Back, Jonathan Weiss, Diana Haines, Draginja Djurickovic, Ewy Mathe, Giang Nguyen, Jonathan Schwank, Mark Bernard, Anne B. Hofseth, Leah Mechanic, Glenwood E. Trivers, Lorne J. Hofseth, Jeffery Subleski, Peijun He, S. Perwez Hussain
Supplementary Figure 8 from Nitric Oxide Is a Key Component in Inflammation-Accelerated Tumorigenesis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1e45d5bfff878ffb4514cdb67ad68bc
https://doi.org/10.1158/0008-5472.22374054
https://doi.org/10.1158/0008-5472.22374054
Autor:
Robert H. Wiltrout, Sylvie Guichard, John R. Ortaldo, Tim Chan, Timothy Back, Jonathan M. Weiss, Qun Jiang
Supplementary Figure 2 from mTOR Kinase Inhibitor AZD8055 Enhances the Immunotherapeutic Activity of an Agonist CD40 Antibody in Cancer Treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4c612fadf74bc39b9b649a4b55c6ed4
https://doi.org/10.1158/0008-5472.22387917
https://doi.org/10.1158/0008-5472.22387917
Autor:
Veena Somasundaram, Timothy Back, Nimit L. Patel, Debashree Basudhar, Joseph D. Kalen, Robert Y.S. Cheng, David A. Wink, Lisa A. Ridnour
Publikováno v:
J Vis Exp
Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype with limited therapeutic options. When compared to patients with less aggressive breast tumors, the 5-year survival rate of TNBC patients is 77% due to their characteristic d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::108f6d8d97f40273570a6c9eddd49784
https://doi.org/10.3791/60316
https://doi.org/10.3791/60316
